Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report Intel FAQ API Sign In →
53 /100
HIGH RISK
Score updated Jul 28, 2026

CNTB — Connect Biopharma Holdings Limited Dilution Risk Tracker

Track CNTB dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track CNTB — Get alerts when the score changes →

As of July 28, 2026, Connect Biopharma Holdings Limited (CNTB) has a DilutionWatch DilutionScore of 53/100, rated HIGH dilution risk. Connect Biopharma Holdings Limited has a market capitalization of $156.78M, 62.96M shares outstanding, 1 institutional holders tracked. Key dilution vectors include approximately 11 months of cash runway.

Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.

Score Breakdown

📋 Offering Ability
40
💰 Cash Runway
65
📊 Float Risk
60
⚠️ Warrant Exposure
40
🔄Convertible Debt

Dilution Forecast

Watch
Minor dilution signals detected
17%
🔄 Reverse Split 25%
• 52-week low $0.73 has breached $1
• 11 months cash with weak price
💰 Capital Raise 15%
• Under 12 months cash (11mo)
🔔 Track CNTB — Get forecast alerts →

Market Data

Market Cap$156.78M
Shares Outstanding62.96M
Float13.40M
Cash$46.03M
Debt$693.0K
Short InterestN/A

Institutional Holdings

QoQ: ↓ 3.0% shares (2026Q1 vs prior)
1 institutional holders · 1.2K shares
#1 EverSource Wealth Advisors, LLC 1.2K shares

Short Interest

Short Interest2.06M
Days to Cover2.8
% of Float15.4%
FINRA data as of Jul 15, 2026

Recent SEC Activity

No recent SEC insights

Recent News

No recent news

What This Means for CNTB Shareholders

Connect Biopharma Holdings Limited (CNTB) has a DilutionScore of 53/100, placing it in the High dilution risk tier. This score reflects at least one active dilution mechanism — a shelf registration, ATM program, outstanding warrants, or limited cash runway — that could materially increase the share count over the next 12–18 months. Score as of July 28, 2026, updated from SEC EDGAR data.

Cash runway is a key watch item: CNTB has approximately 11 months of runway at current burn rate. Companies with less than 18 months of runway are statistically more likely to file new shelf registrations or ATM programs within the next two quarters. DilutionWatch monitors SEC 10-Q filings to update this estimate each quarter.

DilutionWatch tracks over 25 SEC filing types for CNTB in real-time, scanning EDGAR every 60 seconds. The DilutionWatch shows real-time score changes for CNTB alongside comparable high-risk stocks. Not financial advice — this analysis is for informational purposes only.

Understanding CNTB's Dilution Risk Factors

Primary Risk Drivers

The most concerning factors in CNTB’s dilution profile are Offering Ability and Cash Runway. Offering Ability scores at a level indicating significant risk, suggesting the company has active programs to raise capital through equity offerings. This directly increases potential share count expansion. Cash Runway is also elevated at a high-risk level, signaling that the company may be nearing a point where it must seek additional funding, which often involves issuing new shares. The combination of these two factors suggests an environment where new capital raises are likely and could significantly dilute existing shareholders.

Factors Currently Not a Concern

Warrant Exposure and Convertible Note Risk are currently low-risk indicators. These suggest that the company has not issued warrants or convertible notes in large quantities that would immediately threaten current share ownership. However, any future issuance of warrants or convertible debt could quickly elevate these scores. For example, if CNTB files a Form S-3 to register additional shares for sale, Warrant Exposure would rise. Similarly, if the company issues convertible notes under SEC rules, Convertible Note Risk would increase significantly.

SEC Filings to Watch

Critical filings to monitor include Form S-3, which signals a company’s intent to register securities for future sale; Form 424B5, often used in shelf offerings that may involve new share issuance; and Form 8-K Item 1.01, which reports material events such as the launch of new financing programs. Additionally, 10-Q filings provide periodic updates on cash levels and financial performance, which can indicate whether the company is approaching a point where dilution becomes more likely.

How Dilution Happens

Dilution occurs when a company issues new shares to raise capital or fulfill obligations. If Offering Ability is high, it means CNTB is actively pursuing equity financing, which increases share count. As Cash Runway declines and the company approaches its cash exhaustion point, the urgency for funding increases, leading to higher likelihood of share issuance. This process directly reduces the ownership percentage of existing shareholders, as each new share dilutes the value of previously held shares.

What Would Make This Worse

A significant deterioration in CNTB’s risk profile would occur if the company initiates a large-scale equity offering or issues convertible debt that converts into shares. Additionally, if cash reserves drop below six months and the company begins issuing warrants or convertible notes, these factors would compound each other, creating a perfect storm of dilution risk. Any major change in financial strategy or a sudden funding need could accelerate this process, pushing the company’s dilution exposure to maximum levels.

Key Insight

While low scores indicate safety, elevated scores signal potential risks that must be monitored closely through SEC filings and financial updates.

How to Monitor CNTB for Dilution Risk

What This Risk Level Means

For a micro-cap operating company like Connect Biopharma Holdings Limited (CNTB), a high dilution risk profile indicates significant exposure to potential equity dilution. With its small market capitalization and limited financial buffer, the company is more vulnerable to capital-raising activities that could reduce existing shareholders' ownership stakes. The elevated risk factors — including Offering Ability, Cash Runway, Float Risk, Warrant Exposure, and Convertible Note Risk — suggest that management may be actively pursuing funding options that could dilute shares. These companies typically operate with minimal cash reserves, making them reliant on external financing, which increases the likelihood of dilutive equity issuance.

What Typically Happens Next

Companies with this risk profile often proceed through capital-raising mechanisms such as shelf registrations or ATM programs to secure funding. In many cases, warrant exercises or convertible note conversions can also occur, especially if the company is nearing financial distress or has a high cash runway score. For micro-cap firms, these activities are often timed to coincide with product milestones or regulatory approvals. Given the elevated risk factors, investors should expect that such companies may frequently issue new shares to meet operational needs, which could lead to substantial dilution over time.

Monitoring Playbook

To track CNTB’s dilution risk effectively, use DilutionWatch to monitor the company's score changes and key metrics. Set alerts for any increase in Offering Ability or Cash Runway scores, as these are strong early indicators of potential issuance activity. Regular checks should be done monthly, but more frequent monitoring is advised during earnings seasons or when significant news emerges. If thresholds are hit, review SEC filings such as S-1s, S-3s, or Form S-4s for upcoming offerings, and check the company's Shelf & ATM Monitor status to see if new equity programs are being filed.

Early Warning Signals

Several specific signals can indicate a worsening risk profile. First, an increase in Offering Ability or Cash Runway scores by 10 points or more within a quarter is a strong red flag. Second, the filing of a new shelf registration or ATM program with the SEC suggests imminent dilution. Third, a sudden spike in Warrant Exposure or Convertible Note Risk scores may indicate that warrants or notes are nearing conversion or that new convertible debt is being issued.

What a Positive Resolution Looks Like

A positive resolution would involve a capital raise that strengthens the company’s balance sheet, such as a successful equity offering or debt refinancing. Alternatively, if warrants expire unexercised or convertible notes are paid down, the dilution risk scores would decrease significantly. Another sign of improvement is when the company demonstrates improved cash runway, which reduces reliance on future equity issuance and lowers Offering Ability risk.

Watch For

Any sudden increase in Offering Ability or Cash Runway scores, especially if followed by SEC filings related to new equity programs.

Full SEC filing analysis available with free account  →
Track CNTB Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking CNTB — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 7,800+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for CNTB
CNTB FDA Catalyst Timeline & Biotech Grade — BiotechSignsCNTB Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.